UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by WealthCollab LLC

WealthCollab LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 41.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89 shares of the healthcare conglomerate’s stock after selling 63 shares during the period. WealthCollab LLC’s holdings in UnitedHealth Group were worth $45,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Western Pacific Wealth Management LP grew its stake in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after acquiring an additional 20 shares during the period. Axiom Financial Strategies LLC boosted its stake in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares during the period. Richwood Investment Advisors LLC increased its stake in UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the period. Finally, 44 Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after buying an additional 21 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Raymond James reaffirmed a “strong-buy” rating and set a $540.00 price objective (down from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Truist Financial reduced their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday, April 21st. Mizuho increased their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $596.86.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $409.23 on Wednesday. The business has a 50 day moving average price of $499.59 and a two-hundred day moving average price of $532.08. The firm has a market cap of $372.49 billion, a PE ratio of 26.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $409.10 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.05%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.